Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In human colon carcinoma HCT-116 and HT-29 cell lines, butyrate alone increased mRNA levels of some enzymes, such as N-acetyltransferases (in particular NAT2).
|
30439556 |
2019 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Smokers with NAT2-T341C, G590A, G857A, A845C, and C481T rapid acetylator allele have a risk of 4.87, 4.25, 4.18, 3.81, and 3.82, respectively, to develop colon cancer.
|
27883249 |
2017 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The frequency of rapid NAT2 genotype was 35% in colon cancer cases, 47% in rectal cancer cases, and 42% in controls (GSTM1 0/0 genotype: 53, 46, and 47%, respectively).
|
22686318 |
2012 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We examined whether our previously reported associations between meat-derived heterocyclic amine (HCA) intake and colon cancer were modified by N-acetyltransferase 1 (NAT1) or 2 (NAT2) genotypes and whether there were differences by race.
|
18022202 |
2008 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
As there is a recent meta-analysis of NAT2 studies on colon cancer (unlike in lung cancer), we have also undertaken a systematic review of NAT2 studies on lung cancer, and we incorporated our results in a meta-analysis consisting of 16 studies, 3,865 lung cancer patients and 6,077 control subjects.
|
16827944 |
2006 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Having GSTM1 present, a CYP1A1 variant allele, and the rapid-acetylator NAT2 imputed phenotype was associated with increased risk of colon cancer (odds ratio = 1.7, 95% confidence interval: 1.2, 2.3).
|
15496536 |
2004 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Participants with one or more first-degree relatives with colon cancer showed a slightly higher prevalence of at-risk genotypes for each locus, but results were statistically significant only for NAT2.
|
12568823 |
2003 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Therefore local activation of HAAs in colon, and hence increased risk to develop colon cancer, is likely to be related to high NAT2 enzyme activity.
|
11099063 |
2000 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer.
|
10680724 |
2000 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study provides little support for an association between meat consumption and colon cancer risk but does provide some, albeit not strong, evidence for a modifying effect of molecular variants of the NAT2 gene.
|
9950235 |
1999 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Neither NAT2 nor GSTM-1 polymorphisms were significantly associated with colon cancer, except among older women, in whom the intermediate/rapid imputed phenotype was associated with increased risk of colon cancer [odds ratio (OR) = 1.4, 95% confidence interval (CI) = 1.0-1.81.
|
9865425 |
1998 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, a marked difference in NAT2*4/NAT2*4 genotype frequency associated with the patients gender was observed pointing to a male-specific effect of this genotype as a risk factor in colon cancer.The arylamine-N-acetyltransferase (E.C.2.3.1.5.)
|
9472690 |
1998 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
NAT2 genotype did not vary with other clinical features of colon cancer, which included Dukes's stage, site of tumour, and sex.
|
9301503 |
1997 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Individuals with NAT2 fast acetylator genotypes may have higher colon cancer risks due to faster conversion of certain carcinogens to mutagens.
|
7743494 |
1995 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We analyzed two such loci, the cytochrome P-450 gene CYP2D6 and the N-acetyltransferase 2 (NAT2) genes, in patients with bladder and colon cancer, respectively.
|
7497646 |
1995 |